AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,157 Cr | ₹785 Cr | ₹792 Cr | ₹562 Cr | ₹576 Cr |
What is the latest Cash Flow from Operating Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,157 Cr |
| Mar2024 | ₹785 Cr |
| Mar2023 | ₹792 Cr |
| Mar2022 | ₹562 Cr |
| Mar2021 | ₹576 Cr |
How is Cash Flow from Operating Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,157 Cr | 47.40 | |
| Mar2024 | ₹785 Cr | -0.89 | |
| Mar2023 | ₹792 Cr | 41.02 | |
| Mar2022 | ₹562 Cr | -2.53 | |
| Mar2021 | ₹576 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹37,029.1 Cr | 0.5% | 5.6% | 16.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 0.5% |
5.6% |
16.7% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses